Uri Ladabaum MD, MSProfessor of Medicine; Director, Gastrointestinal Cancer Prevention Program, Stanford University School of Medicine, Stanford, California
Uri Ladabaum, MD, MS, serves as director of the Gastrointestinal Cancer Prevention Program and heads the Clinical Service of the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Dr. Ladabaum received his medical degree from the University of California, San Francisco, completed his residency and chief residency in internal medicine at Stanford University Hospital, and fellowship in gastroenterology at the University of Michigan, where he also obtained an MS degree in clinical research design and statistical analysis.
Dr. Ladabaum’s clinical efforts include providing consultation and endoscopic services for persons at average risk or high risk for cancer, and caring for patients and families with suspected or established inherited cancer predisposition syndromes.
Dr. Ladabaum’s research focus is colorectal cancer risk management and prevention. His current and recent areas of investigation include risk stratification and personalized screening, cost-effectiveness analyses of multiple questions related to colorectal cancer screening, quality monitoring and assurance in endoscopy, safety of colonoscopy, and identification and management of families with genetic cancer syndromes.
DisclosuresDr. Ladabaum reports the following:
- Advisor: Universal Dx, Lean Medical
- Active Consulting: Freenome, Guardant, Medtronic, Neptune Medical, Kohler Ventures
- Recent Consulting: Geneoscopy, Meidal EarlySign, ChekCap